File Download
Links for fulltext
(May Require Subscription)
- Find via
Supplementary
-
Citations:
- Appears in Collections:
Conference Paper: Massive degradation in FGFR/Akt/Erk signaling by arsenic trioxide and FGFR inhibitor PD173074 in squamous cell lung carcinoma SK-MES-1
| Title | Massive degradation in FGFR/Akt/Erk signaling by arsenic trioxide and FGFR inhibitor PD173074 in squamous cell lung carcinoma SK-MES-1 |
|---|---|
| Authors | |
| Keywords | Medical sciences |
| Issue Date | 2015 |
| Publisher | Hong Kong Academy of Medicine Press. The Journal's web site is located at http://www.hkmj.org.hk |
| Citation | The 20th Medical Research Conference (MRC 2015), Hong Kong, 17 January 2015. In Hong Kong Medical Journal, 2015, v. 21 suppl. 1, p. 30, abstract no. 41 How to Cite? |
| Abstract | INTRODUCTION: Lung cancer is the top cancer killer. Squamous cell carcinoma (SCC) represents the second most common histological subtype of lung cancer. Arsenic trioxide (ATO) has been demonstrated to inhibit tumour growth in lung adenocarcinoma and initiate apoptosis in acute promyelocytic leukaemia. Fibroblast growth factor (FGF) receptor (FGFR) amplification is shown in some SCC. FGFR inhibitor (eg PD173074) has been … |
| Description | This journal suppl. entitled: 20th Medical Research Conference; Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong |
| Persistent Identifier | http://hdl.handle.net/10722/208746 |
| ISSN | 2021 Impact Factor: 1.256 2020 SCImago Journal Rankings: 0.357 |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Lam, SK | - |
| dc.contributor.author | Leung, LL | - |
| dc.contributor.author | Ho, JCM | - |
| dc.date.accessioned | 2015-03-18T09:09:17Z | - |
| dc.date.available | 2015-03-18T09:09:17Z | - |
| dc.date.issued | 2015 | - |
| dc.identifier.citation | The 20th Medical Research Conference (MRC 2015), Hong Kong, 17 January 2015. In Hong Kong Medical Journal, 2015, v. 21 suppl. 1, p. 30, abstract no. 41 | - |
| dc.identifier.issn | 1024-2708 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/208746 | - |
| dc.description | This journal suppl. entitled: 20th Medical Research Conference; Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong | - |
| dc.description.abstract | INTRODUCTION: Lung cancer is the top cancer killer. Squamous cell carcinoma (SCC) represents the second most common histological subtype of lung cancer. Arsenic trioxide (ATO) has been demonstrated to inhibit tumour growth in lung adenocarcinoma and initiate apoptosis in acute promyelocytic leukaemia. Fibroblast growth factor (FGF) receptor (FGFR) amplification is shown in some SCC. FGFR inhibitor (eg PD173074) has been … | - |
| dc.language | eng | - |
| dc.publisher | Hong Kong Academy of Medicine Press. The Journal's web site is located at http://www.hkmj.org.hk | - |
| dc.relation.ispartof | Hong Kong Medical Journal | - |
| dc.rights | Hong Kong Medical Journal. Copyright © Hong Kong Academy of Medicine Press. | - |
| dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
| dc.subject | Medical sciences | - |
| dc.title | Massive degradation in FGFR/Akt/Erk signaling by arsenic trioxide and FGFR inhibitor PD173074 in squamous cell lung carcinoma SK-MES-1 | - |
| dc.type | Conference_Paper | - |
| dc.identifier.email | Lam, SK: sklam77@hku.hk | - |
| dc.identifier.email | Ho, JCM: jhocm@hku.hk | - |
| dc.identifier.authority | Ho, JCM=rp00258 | - |
| dc.description.nature | published_or_final_version | - |
| dc.identifier.hkuros | 242621 | - |
| dc.identifier.volume | 21 | - |
| dc.identifier.issue | suppl. 1 | - |
| dc.identifier.spage | 30, abstract no. 41 | - |
| dc.identifier.epage | 30, abstract no. 41 | - |
| dc.publisher.place | Hong Kong | - |
| dc.identifier.issnl | 1024-2708 | - |